This trial is testing whether the medication DEXYCU is safe for treating inflammation following ocular surgery for childhood cataract.
1 Primary · 1 Secondary · Reporting Duration: Post-Operative Day 14
Active Control
Experimental Treatment
60 Total Participants · 2 Treatment Groups
Primary Treatment: Dexamethasone · No Placebo Group · Phase 4
Age < 18 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: